Paul A Mahon United Therapeutics Corp (UTHR) insider trading activity

Paul A Mahon is EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 36,781 shares of UTHR, which is worth approximately $11.2 Million. The most recent transaction as insider was on May 01, 2025, when has been sold 11,000 shares (Common Stock) at a price of $299.31 per share, resulting in proceeds of $3,292,410. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.8K

0.19% 3M change

0.19% 12M change

Total Value Held $11.2 Million

PAUL A MAHON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
May 01 2025	SELL Open market or private sale	$3,292,410 $299.31 p/Share	11,000 Reduced 23.02%	36,781 Common Stock
May 01 2025	BUY Exercise of conversion of derivative security	$1,295,360 $117.76 p/Share	11,000 Added 18.71%	47,781 Common Stock
Apr 17 2025	SELL Open market or private sale	$3,112,450 $282.95 p/Share	11,000 Reduced 23.02%	36,781 Common Stock
Apr 17 2025	BUY Exercise of conversion of derivative security	$1,295,360 $117.76 p/Share	11,000 Added 18.71%	47,781 Common Stock
Apr 03 2025	SELL Open market or private sale	$3,345,430 $304.13 p/Share	11,000 Reduced 23.02%	36,781 Common Stock
Apr 03 2025	BUY Exercise of conversion of derivative security	$1,295,360 $117.76 p/Share	11,000 Added 18.71%	47,781 Common Stock
Mar 06 2025	SELL Sale (or disposition) back to the issuer	$2,015,304 $307.68 p/Share	6,550 Reduced 15.12%	36,781 Common Stock
Mar 06 2025	BUY Exercise of conversion of derivative security	$1,069,615 $163.3 p/Share	6,550 Added 13.13%	43,331 Common Stock
Feb 20 2025	SELL Sale (or disposition) back to the issuer	$2,828,672 $367.36 p/Share	7,700 Reduced 17.34%	36,710 Common Stock
Feb 20 2025	BUY Exercise of conversion of derivative security	$1,257,410 $163.3 p/Share	7,700 Added 14.78%	44,410 Common Stock
Feb 06 2025	SELL Sale (or disposition) back to the issuer	$2,723,875 $353.75 p/Share	7,700 Reduced 17.34%	36,710 Common Stock
Feb 06 2025	BUY Exercise of conversion of derivative security	$1,257,410 $163.3 p/Share	7,700 Added 14.78%	44,410 Common Stock
Jan 16 2025	SELL Sale (or disposition) back to the issuer	$2,821,203 $366.39 p/Share	7,700 Reduced 17.34%	36,710 Common Stock
Jan 16 2025	BUY Exercise of conversion of derivative security	$1,257,410 $163.3 p/Share	7,700 Added 14.78%	44,410 Common Stock
Jan 02 2025	SELL Sale (or disposition) back to the issuer	$2,773,694 $360.22 p/Share	7,700 Reduced 17.34%	36,710 Common Stock
Jan 02 2025	BUY Exercise of conversion of derivative security	$1,257,410 $163.3 p/Share	7,700 Added 14.78%	44,410 Common Stock
Dec 19 2024	SELL Sale (or disposition) back to the issuer	$2,773,232 $360.16 p/Share	7,700 Reduced 17.34%	36,710 Common Stock
Dec 19 2024	BUY Exercise of conversion of derivative security	$1,257,410 $163.3 p/Share	7,700 Added 14.78%	44,410 Common Stock
Dec 05 2024	SELL Open market or private sale	$2,882,649 $374.37 p/Share	7,700 Reduced 17.34%	36,710 Common Stock
Dec 05 2024	BUY Exercise of conversion of derivative security	$1,257,410 $163.3 p/Share	7,700 Added 14.78%	44,410 Common Stock
Nov 21 2024	SELL Open market or private sale	$2,828,672 $367.36 p/Share	7,700 Reduced 17.34%	36,710 Common Stock
Nov 21 2024	BUY Exercise of conversion of derivative security	$1,257,410 $163.3 p/Share	7,700 Added 14.78%	44,410 Common Stock
Nov 07 2024	SELL Sale (or disposition) back to the issuer	$3,099,789 $402.57 p/Share	7,700 Reduced 17.34%	36,710 Common Stock
Nov 07 2024	BUY Exercise of conversion of derivative security	$1,257,410 $163.3 p/Share	7,700 Added 14.78%	44,410 Common Stock
Oct 17 2024	SELL Sale (or disposition) back to the issuer	$2,870,637 $372.81 p/Share	7,700 Reduced 17.34%	36,710 Common Stock

PAM

Paul A Mahon

EVP & GENERAL COUNSEL

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Any

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account